NLEM impact: Sanofi's flagship insulin Lantus to take ₹110 cr hit Nirmal Bang says it estimates Lantus’ annual sales in India for Sanofi at ₹550 crore and hence the impact due to price reduction on revenue would be ₹110 crore. By Joe Mathew
India’s FATF scorecard: ‘Largely compliant’ but precious metals & stones sectors pose money laundering risks
India’s FATF scorecard: ‘Largely compliant’ but precious metals & stones sectors pose money laundering risks
